Skip to content

Celcuity CELC Debt-to-assets

Debt-to-assets at other companies

Eli Lilly logo
Eli LillyLLY
0.4×-0.1×
Gilead Sciences logo
Gilead SciencesGILD
0.4×0.0×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
2.4×+2.4×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
0.0×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
0.0×
Tango Therapeutics logo
Tango TherapeuticsTNGX
0.1×-0.1×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on the most recent quarter.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's debt-to-assets?
Celcuity (CELC) reported debt-to-assets of 0.3× in Q1 2026.
How has Celcuity's debt-to-assets changed year-over-year?
Celcuity's debt-to-assets decreased by 30.5% year-over-year, from 0.5× to 0.3×.
What is the long-term trend for Celcuity's debt-to-assets?
Over 5 years (2020 to 2025), Celcuity's debt-to-assets has grown at a 65.6% compound annual growth rate (CAGR), from 0× to 0.3×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.